Vincent Metzler

Vincent Metzler is an accomplished biopharmaceutical executive with extensive experience in the industry. He currently serves as the Chief Executive Officer (CEO) of Kither Biotech, a biopharmaceutical company focused on developing novel therapies for rare respiratory diseases.14

Dr. Metzler's career highlights include:

1. Appointment as CEO: In March 2022, Dr. Metzler was appointed as the CEO of Kither Biotech, transitioning from his role as a Board Member.13

2. Board Experience: He had been serving on the Board of Directors of Kither Biotech since June 2020, bringing over 20 years of experience in commercial operations in the pharmaceutical and biotech sectors.14

3. Previous Roles:

   • Vice President, Head of Marketing and Commercial Operations, Europe at Atara Biotherapeutics, an immunotherapy company.1
   • Member of the Executive Leadership Team at Wilson Therapeutics, a Swedish clinical-stage biotech company.1

4. Educational Background: Dr. Metzler holds a Ph.D. in gene therapy, specifically using antisense RNA technology.

5. Recent Developments: As of November 2023, Dr. Metzler has joined Phraktion as a partner, further expanding his involvement in the biopharmaceutical industry.5

Dr. Metzler's expertise spans commercial operations, marketing, and leadership in the pharmaceutical and biotech industries. His appointment as CEO of Kither Biotech coincided with the company's €18.5 million Series B funding round, positioning him to lead the company through its next growth phase, including the clinical development of its lead candidate KIT2014 for cystic fibrosis.12